Publications by authors named "Jeanne Lusher"

Claim this Profile
C
Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.
Veronica H Flood, Pamela A Christopherson, Joan Cox Gill, Kenneth D Friedman, Sandra L Haberichter, Jeanne M Lusher

Blood· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A longer acting rFVIII, safe and effective.
Jeanne M Lusher

Blood· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonance.
Kenneth B Lewis, Richard J Hughes, Melinda S Epstein, Neil C Josephson, Christine L Kempton, Jeanne M Lusher

PLoS One· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergency department visits in children with hemophilia.
Bülent Özgönenel, Ayesha Zia, Michael U Callaghan, Meera Chitlur, Madhvi Rajpurkar, Jeanne M Lusher

Pediatr Blood Cancer· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.
Veronica H Flood, Kenneth D Friedman, Joan Cox Gill, Sandra L Haberichter, Pamela A Christopherson, Jeanne M Lusher

Blood· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.
Daniel B Bellissimo, Pamela A Christopherson, Veronica H Flood, Joan Cox Gill, Kenneth D Friedman, Jeanne M Lusher

Blood· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A community-based partnership to promote information infrastructure for bleeding disorders.
Diane J Aschman, Thomas C Abshire, Amy D Shapiro, Jeanne M Lusher, Ann D Forsberg

Am J Prev Med· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma homocysteine levels, methylene tetrahydrofolate reductase polymorphisms, and the risk of thromboembolism in children.
Akash Nahar, Cynthia Sabo, Meera Chitlur, Yaddanapudi Ravindranath, Jeanne Lusher

J Pediatr Hematol Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of thromboelastography: values and challenges.
Meera Chitlur, Jeanne Lusher

Semin Thromb Hemost· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.
Veronica H Flood, Joan Cox Gill, Patricia A Morateck, Pamela A Christopherson, Kenneth D Friedman, Jeanne M Lusher

Blood· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrinolytic parameters in children with noncatheter thrombosis: a pilot study.
O Alphan Kupesiz, Meera B Chitlur, Wendy Hollon, Ozgun Tosun, Ronald Thomas, Jeanne M Lusher

Blood Coagul Fibrinolysis· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue plasminogen activator induced fibrinolysis: standardization of method using thromboelastography.
Alphan Kupesiz, Madhvi Rajpurkar, Indira Warrier, Wendy Hollon, Ozgur Tosun, Jeanne Lusher

Blood Coagul Fibrinolysis· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of recombinant factor VIII safety: KOGENATE and Kogenate FS/Bayer.
Jeanne M Lusher, Inge Scharrer

Int J Hematol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia.
Zhihong J Wang, Nkechi Onwuzurike, Michael U Callaghan, Madhvi Rajpurkar, Meera Chitlur, Jeanne M Lusher

Pediatr Blood Cancer· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thromboelastography in children with coagulation factor deficiencies.
Meera Chitlur, Indira Warrier, Madhvi Rajpurkar, Wendy Hollon, Lolita Llanto, Jeanne M Lusher

Br J Haematol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary embolism-experience at a single children's hospital.
Madhvi Rajpurkar, Indira Warrier, Meera Chitlur, Cynthia Sabo, Mary Jane Frey, Jeanne Lusher

Thromb Res· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection.
Darintr Sosothikul, Panya Seksarn, Sureeporn Pongsewalak, Usa Thisyakorn, Jeanne Lusher

Thromb Haemost· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How do you treat bleeding disorders with desmopressin?
Bülent Ozgönenel, Madhvi Rajpurkar, Jeanne M Lusher

Postgrad Med J· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric reference values for molecular markers in hemostasis.
Darintr Sosothikul, Panya Seksarn, Jeanne M Lusher

J Pediatr Hematol Oncol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Milestones in hemophilia and concepts in future clinical trial design.
Jeanne M Lusher

Semin Hematol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigation.
Wolfhart Kreuz, Joan C Gill, Chantal Rothschild, Marilyn J Manco-Johnson, Jeanne M Lusher

Thromb Haemost· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B.
Amy D Shapiro, Jorge Di Paola, Alice Cohen, K John Pasi, Margaret A Heisel, Jeanne M Lusher

Blood· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion.
Jerry S Powell, Margaret V Ragni, Gilbert C White, Jeanne M Lusher, Carol Hillman-Wiseman

Blood· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First and second generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy, and inhibitor development.
Jeanne M Lusher

Semin Thromb Hemost· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highlights from the XXV International Congress of the World Federation of Hemophilia. May 19-24, 2002, Seville, Spain.
Jeanne M Lusher,

MedGenMed· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis